Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2017

01-11-2017

Survey of primary care providers’ knowledge of screening for, diagnosing and managing prediabetes

Authors: Eva Tseng, MD MPH, Raquel C. Greer, MD MHS, Paul O’Rourke, MD MPH, Hsin-Chieh Yeh, PhD, Maura M. McGuire, MD, Jeanne M. Clark, MD MPH, Nisa M. Maruthur, MD MHS

Published in: Journal of General Internal Medicine | Issue 11/2017

Login to get access

Abstract

Background

Prediabetes affects 86 million US adults, but primary care providers’ (PCPs') knowledge, practices, attitudes and beliefs toward prediabetes are unclear.

Objective

Assess PCPs’ (1) knowledge of risk factors that should prompt prediabetes screening, laboratory criteria for diagnosing prediabetes and guidelines for management of prediabetes; (2) management practices around prediabetes; (3) attitudes and beliefs about prediabetes.

Design

Self-administered written survey of PCPs.

Participants

One hundred forty of 155 PCPs (90%) attending an annual provider retreat for academically affiliated multispecialty practices in the mid-Atlantic region.

Main measures

Descriptive analyses of survey questions on knowledge, management, and attitudes and beliefs related to prediabetes. Multivariate logistic regression was used to determine the association between provider characteristics (gender, race/ethnicity, years since training, specialty and provider type) and knowledge, management, and attitudes and beliefs about prediabetes.

Key results

Six percent of PCPs correctly identified all of the risk factors that should prompt prediabetes screening. Only 17% of PCPs correctly identified the laboratory parameters for diagnosing prediabetes based on both fasting glucose and hemoglobin A1c. Nearly 90% of PCPs reported close follow-up (within 6 months) of patients with prediabetes. Few PCPs (11%) selected referral to a behavioral weight loss program as the recommended initial management approach to prediabetes. PCPs agreed that patient-related factors are important barriers to lifestyle change and metformin use. Provider characteristics were generally not associated with knowledge, management, attitudes and beliefs about prediabetes in multivariate analyses.

Conclusions

Addressing gaps in knowledge and the underutilization of behavioral weight loss programs in prediabetes are two essential areas where PCPs could take a lead in curbing the diabetes epidemic.
Appendix
Available only for authorised users
Literature
2.
go back to reference Centers for Disease Control and Prevention (CDC). Awareness of prediabetes—United States, 2005-2010. MMWR Morb Mortal Wkly Rep. 2013;62(11):209–212. Centers for Disease Control and Prevention (CDC). Awareness of prediabetes—United States, 2005-2010. MMWR Morb Mortal Wkly Rep. 2013;62(11):209–212.
3.
4.
go back to reference American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(Suppl. 1): S11–24.CrossRef American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(Suppl. 1): S11–24.CrossRef
5.
go back to reference Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–841.CrossRef Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–841.CrossRef
6.
go back to reference Gong Q, Zhang P, Wang J, Gregg EW, Li H, Zhang B, et al. Changes in mortality in people with IGT before and after the onset of diabetes during the 23-year follow-up of the Da Qing Diabetes Prevention Study. Diabetes Care. 2016;39(9):1550–1555.CrossRefPubMedPubMedCentral Gong Q, Zhang P, Wang J, Gregg EW, Li H, Zhang B, et al. Changes in mortality in people with IGT before and after the onset of diabetes during the 23-year follow-up of the Da Qing Diabetes Prevention Study. Diabetes Care. 2016;39(9):1550–1555.CrossRefPubMedPubMedCentral
7.
go back to reference Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–1686.CrossRefPubMedCentral Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–1686.CrossRefPubMedCentral
8.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.CrossRefPubMed Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.CrossRefPubMed
9.
go back to reference Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: The diabetes prevention program outcomes study. Lancet Diabetes Endocrinol. 2015. Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: The diabetes prevention program outcomes study. Lancet Diabetes Endocrinol. 2015.
10.
go back to reference American Diabetes Association. Prevention or delay of type 2 diabetes. Diabetes Care. 2017;40(Supplement 1):S44–S47. American Diabetes Association. Prevention or delay of type 2 diabetes. Diabetes Care. 2017;40(Supplement 1):S44–S47.
12.
go back to reference Rhee MK, Herrick K, Ziemer DC, Vaccarino V, Weintraub WS, Narayan KM, et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care. 2010;33(1):49–54.CrossRefPubMed Rhee MK, Herrick K, Ziemer DC, Vaccarino V, Weintraub WS, Narayan KM, et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care. 2010;33(1):49–54.CrossRefPubMed
13.
go back to reference Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic US adults. Diabetes Care. 2010;33(11):2355–2359.CrossRefPubMedPubMedCentral Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic US adults. Diabetes Care. 2010;33(11):2355–2359.CrossRefPubMedPubMedCentral
14.
go back to reference Schmittdiel JA, Adams SR, Segal J, Griffin MR, Roumie CL, Ohnsorg K, et al. Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: Brief report from an integrated electronic health records pilot study. Diabetes Care. 2014;37(2):565–568.CrossRefPubMedPubMedCentral Schmittdiel JA, Adams SR, Segal J, Griffin MR, Roumie CL, Ohnsorg K, et al. Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: Brief report from an integrated electronic health records pilot study. Diabetes Care. 2014;37(2):565–568.CrossRefPubMedPubMedCentral
15.
go back to reference Moin T, Li J, Duru OK, Ettner S, Turk N, Keckhafer A, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med. 2015;162(8):542–548.CrossRefPubMedPubMedCentral Moin T, Li J, Duru OK, Ettner S, Turk N, Keckhafer A, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med. 2015;162(8):542–548.CrossRefPubMedPubMedCentral
16.
go back to reference Siu AL, U S Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(11):861–868.CrossRefPubMed Siu AL, U S Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(11):861–868.CrossRefPubMed
17.
go back to reference Shah BR, Hwee J, Anand SS, Austin PC, Manuel DG, Hux JE. Family physician ethnicity influences quality of diabetes care for Chinese but not South Asian patients. Prim Care Diabetes. 2015;9(6):432–8.CrossRefPubMed Shah BR, Hwee J, Anand SS, Austin PC, Manuel DG, Hux JE. Family physician ethnicity influences quality of diabetes care for Chinese but not South Asian patients. Prim Care Diabetes. 2015;9(6):432–8.CrossRefPubMed
18.
go back to reference Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care. 2007;30(3):753–759.CrossRefPubMed Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care. 2007;30(3):753–759.CrossRefPubMed
19.
go back to reference Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–1465.CrossRefPubMed Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–1465.CrossRefPubMed
20.
go back to reference Chan WV, Pearson TA, Bennett GC, Cushman WC, Gaziano TA, Gorman PN, et al. ACC/AHA Special Report: Clinical practice Guideline Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(8):1076–1092.CrossRefPubMed Chan WV, Pearson TA, Bennett GC, Cushman WC, Gaziano TA, Gorman PN, et al. ACC/AHA Special Report: Clinical practice Guideline Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(8):1076–1092.CrossRefPubMed
21.
go back to reference Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330(7494):765.CrossRefPubMedPubMedCentral Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330(7494):765.CrossRefPubMedPubMedCentral
23.
go back to reference Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–544.CrossRefPubMed Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–544.CrossRefPubMed
24.
go back to reference Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish Diabetes Prevention Study (DPS). Diabetes Care. 2003;26(12):3230–3236. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish Diabetes Prevention Study (DPS). Diabetes Care. 2003;26(12):3230–3236.
26.
27.
go back to reference Mainous AG, Tanner RJ, Scuderi CB, Porter M, Carek PJ. Prediabetes screening and treatment in diabetes prevention: the impact of physician attitudes. J Am Board Fam Med. 2016;29(6):663–671. Mainous AG, Tanner RJ, Scuderi CB, Porter M, Carek PJ. Prediabetes screening and treatment in diabetes prevention: the impact of physician attitudes. J Am Board Fam Med. 2016;29(6):663–671.
Metadata
Title
Survey of primary care providers’ knowledge of screening for, diagnosing and managing prediabetes
Authors
Eva Tseng, MD MPH
Raquel C. Greer, MD MHS
Paul O’Rourke, MD MPH
Hsin-Chieh Yeh, PhD
Maura M. McGuire, MD
Jeanne M. Clark, MD MPH
Nisa M. Maruthur, MD MHS
Publication date
01-11-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4103-1

Other articles of this Issue 11/2017

Journal of General Internal Medicine 11/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.